Raw microarray files were processed in RStudio (65) (version 0.98.501) using R (66) (version format (CDF) (GEO platform GPL6244) which organizes the probes into 33,297 transcripts. CEL files were organized into four phenotypic categories according to the descriptions in Table   1 4 5
1, including four biological replicates at each of the four radiation doses of 0.0 Gy (control), 0.3
Gy, 1.5 Gy, and 3.0 Gy. A single contrast matrix was constructed in order to complete three 1 4 7
dose-dependent comparisons: 0.3 Gy (n=4) vs. control (n=4); 1.5 Gy (n=4) vs. control; and 3.0 at time 1 hr). In addition to protein coding genes, a small number of non-coding microRNAs 2 4 1 (miRNAs) were found to be differentially expressed ( regulated at 3.0 Gy, has been shown to serve as a cardiac-specific miRNA by controlling
expression of the cardiac muscle myosin heavy chain 7b, MYH7B (97). Differentially expressed ncRNAs
In addition to miRNAs, a number of non-coding RNAs (ncRNAs) were determined to be significantly differentially expressed, particularly at higher radiation levels (Table 5 ; Fig 5) .
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Among these were long, non-coding RNAs (lncRNAs), small nuclear RNAs (snRNAs), and ribosomal RNA maturation. Interestingly, a number of the significant differentially expressed probes belonged to 2 8 8 pseudogenes for both protein coding and non-coding RNAs (Fig 6) . Among the up-regulated 2 8 9 pseudogenes were a number of ribosomal associated pseudogenes; two that were associated with 2 9 0 olfaction (VN2R17P, OR2U1P); and one, GCOM2 (GRINC1B complex locus 2, pseudogene) 2 9 1 that was implicated in both myeloid leukemia (98) and telomeric repeat binding (99). The majority of the down-regulated pseudogenes were pseudogenes for the 2 9 8 mitochondrially encoded NADH dehydrogenase 1 (MTND1) or were related to ATP activity,
suggesting the down-regulation of mitochondrial specific pseudogenes which may act as sponges showed a molecular response to detection of chemical stimulus that was independent of the 3 0 7
dosage. This agreed with prior studies that showed radiation exposure induced olfactory (Table 7) . Previous work showed that global changes in the metabolome occurred with radiation and secretion at 0.3 Gy; increased immune response at 3.0 Gy; decreased cAMP biosynthesis and 3 2 7 metabolism at 1.5 Gy; and decreased T-cell migration at 1.5 Gy. DEGs at 1 hr post-exposure. were oxidative phosphorylation which, along with mitochondrial electron transport, is increased
with ionizing radiation exposure (106-109). In addition, the ribosome pathway was enriched at 3 4 1 3.0 Gy. This was consistent with an increase in small RNA molecules responsible for rRNA 3 4 2 maturation (Table 5 ) and previous results (110, 111). DEGs at 1 hr post-exposure. of differentially expressed transcripts were dose-dependent (Fig 2) . The top 10 significant dose-3 5 3 dependent, differentially expressed transcripts are shown in Table 9 for each of the three 3 5 4 radiation doses. suggest that cell adhesion and signaling were affected at low-dose radiation (0.3 Gy), consistent events. In general, differentially expressed transcripts detected within microarray experiments yield 3 7 7 biomarkers sensitive to a specific condition when all other factors are reasonably controlled.
7 8
However, in order for a biomarker to be useful in terms of a diagnostic test, it must also be 3 7 9
specific to the condition being tested. For example, within our dataset, PCNA (proliferating cell 3 8 0 nuclear antigen) was highly differentially expressed at both 1.5 Gy and 3.0 Gy, but has been 3 8 1 determined to be differentially regulated under a large number of conditions. Using the methodology for determining sensitive and specific transcriptional biomarkers (Table 11) , while 20 genes at 1.5 Gy (Table 12 ) and 23 genes at 3.0 Gy were considered (Table 13 ). Only one of these genes, KDELC1 (KDEL (Lys-Asp-Glu-Leu) 3 8 6 containing 1) was found to be differentially expressed at all three radiation levels, while MRPS30 (hexamethylene bis-acetamide inducible 1) were found to be differentially expressed at both 1.5 3 8 9
Gy and 3.0 Gy. For each of the datasets of possible transcriptional biomarkers, we then looked 3 9 0 at their pairwise occurrence within GEO DataSets. From this analysis, we focused on the three 3 9 1 potential transcriptional biomarkers with the fewest pairwise occurrences within the list (Tables   3  9  2 14-16). For 0.3 Gy, this yielded PRDM9 (PR domain containing 9), CHST4 (carbohydrate (N- (WDYHV motif containing 1), and IFNA16 (interferon, alpha 16) while those detected at 3.0 Gy included CWC15 (CWC15 spliceosome-associated protein), CHCHD7 (coiled-coil-helix-coiled-3 9 8 helix domain containing 7), and DNAAF2 (dynein, axonemal, assembly factor 2). CEP57L1  IFNA5  GABRA2  KCNJ6  TIPIN  ZFHX4  E2F5  DLG2  DNAAF2  ARHGAP6  TNNI3K  HDAC2  MRPS30 †  TIMM9  KDELC1*  VTCN1  IL12A  HSD17B3  TM2D1 As a result of this study, we were also able to elucidate additional transcriptional opposite direction on complementary DNA strands. This particular SAGP is part of a group of 4 6 0 12 whose differential expression has been determined to be highly predictive of breast cancer Our transcriptional profile has led to a number of elucidated transcriptional biomarkers related processes and show a specificity and sensitivity that make them prime candidates for making their use as transcriptional biomarkers subject to additional scrutiny. As the KDELC1 4 7 2
